{"id":"CHEMBL1079905","canonicalSmiles":"CCCn1cnc2c1c(=O)n(CCCCC(C)=O)c(=O)n2C","inchiKey":"RBQOQRRFDPXAGN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PROPENTOFYLLINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["HWA 285","HWA-285","NSC-752424","Propentofylline","Propentophylline"],"crossReferences":{"PubChem":["104171224","11111693","144203798","170465624","26753633","49645640","50106916","85231201","90340930"],"drugbank":["DB06479"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1085699","canonicalSmiles":"COC(=O)C1=C(C)NC(C)=C(C(=O)OCCN2CCN(C(c3ccccc3)c3ccccc3)CC2)C1c1cccc([N+](=O)[O-])c1","inchiKey":"ANEBWFXPVPTEET-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MANIDIPINE 6300","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Artedil","Franidipine","Manidipine","Manidipine 6300","Manidipine hydrochloride"],"crossReferences":{"PubChem":["174006297","50112746"],"drugbank":["DB09238"]},"childChemblIds":["CHEMBL2362693"],"linkedTargets":{"rows":["ENSG00000157388","ENSG00000081248","ENSG00000102001","ENSG00000151067"],"count":4},"linkedDiseases":{"rows":["EFO_0000319","EFO_0000537"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1159","canonicalSmiles":"CC(N/C(=N\\C#N)Nc1ccncc1)C(C)(C)C","inchiKey":"IVVNZDGDKPTYHK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PINACIDIL","yearOfFirstApproval":1989,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Pindac"],"synonyms":["Pinacidil"],"crossReferences":{"PubChem":["11532877","124881033","26749106","26752206","50104869","56463565","90341497"],"Wikipedia":["Pinacidil"],"drugbank":["DB06762"]},"childChemblIds":["CHEMBL1200338"],"linkedTargets":{"rows":["ENSG00000069431"],"count":1},"linkedDiseases":{"rows":["EFO_0000537"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1989 and is indicated for hypertension."}
{"id":"CHEMBL1183717","canonicalSmiles":"C=CCNc1nc(NCC=C)nc(N2CCN(C(c3ccc(F)cc3)c3ccc(F)cc3)CC2)n1","inchiKey":"OBDOVFRMEYHSQB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ALMITRINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Almitrine"],"crossReferences":{"drugbank":["DB01430"],"chEBI":["53778"]},"childChemblIds":["CHEMBL314610","CHEMBL3181957"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for respiratory system disease and has 2 investigational indications."}
{"id":"CHEMBL1200335","canonicalSmiles":"CCCCCCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C","inchiKey":"VOCBWIIFXDYGNZ-IXKNJLPQSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"TESTOSTERONE ENANTHATE","yearOfFirstApproval":1953,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Delatestryl","Primoteston depot","Testosterone enanthate","Xyosted (autoinjector)"],"synonyms":["Androtardyl","NSC-17591","Testosterone enantate","Testosterone enanthate","Testosterone enanthate ciii","Testosterone heptanoate","Testosteroni enantas","Xyosted"],"crossReferences":{"DailyMed":["testosterone%20enanthate"],"drugbank":["DB13944"],"chEBI":["9464"]},"linkedTargets":{"rows":["ENSG00000169083"],"count":1},"linkedDiseases":{"rows":["HP_0000044","EFO_0007312","EFO_1000653","MONDO_0002146","EFO_0000196","EFO_0000673","Orphanet_269","EFO_0000341","HP_0001824","MONDO_0008315","MONDO_0018555"],"count":11},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1953 and is indicated for hypogonadotropic hypogonadism and hypogonadism and has 7 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1200432","canonicalSmiles":"CCOC(=O)[C@@](C)(N)Cc1ccc(O)c(O)c1.Cl","inchiKey":"QSRVZCCJDKYRRF-YDALLXLXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METHYLDOPATE HYDROCHLORIDE","yearOfFirstApproval":1962,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201233","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Aldomet","Methyldopate hydrochloride"],"synonyms":["Methyldopa l-form ethyl ester hydrochloride","Methyldopate hcl","Methyldopate hydrochloride","NSC-760088"],"crossReferences":{"PubChem":["144204076","170466856"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1962."}
{"id":"CHEMBL1200459","canonicalSmiles":"O=P([O-])([O-])O.[K+].[K+]","inchiKey":"ZPWVASYFFYYZEW-UHFFFAOYSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"POTASSIUM PHOSPHATE, DIBASIC","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Isolyte","Neutra-Phos"],"synonyms":["Dibasic potassium phosphate","E-340(II)","INS NO.340(II)","INS-340(II)","Potassium phosphate dibasic","Potassium phosphate, dibasic"],"crossReferences":{"DailyMed":["potassium%20phosphate,%20dibasic"],"DrugCentral":["4206"],"Wikipedia":["Dipotassium_phosphate"],"drugbank":["DB09414"],"chEBI":["32031"]},"description":"Small molecule drug with a maximum clinical trial phase of IV and has 1 investigational indication."}
{"id":"CHEMBL1200491","canonicalSmiles":"Cl.NC1=NCC2c3ccccc3Cc3ccccc3N12","inchiKey":"VKXSGUIOOQPGAF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EPINASTINE HYDROCHLORIDE","yearOfFirstApproval":2003,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1106","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Elestat","Epinastine hydrochloride","Relestat"],"synonyms":["Alesion","DE-114","Epinastine HCl","Epinastine hcl","Epinastine hydrochloride","WAL 801 CL","WAL-801CL","WAL-802-CL"],"crossReferences":{"DailyMed":["epinastine%20hydrochloride"],"PubChem":["144205816","170465284"],"chEBI":["51037"]},"linkedTargets":{"rows":["ENSG00000196639"],"count":1},"linkedDiseases":{"rows":["EFO_0007141"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2003 and is indicated for allergic conjunctivitis."}
{"id":"CHEMBL1200706","canonicalSmiles":"[Al+3].[OH-].[OH-].[OH-]","inchiKey":"WNROFYMDJYEPJX-UHFFFAOYSA-K","drugType":"Small molecule","blackBoxWarning":false,"name":"ALUMINUM HYDROXIDE","yearOfFirstApproval":1983,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Alu-cap","Aludrox","Amphojel","Dialume","Sarpep"],"synonyms":["Aluminium hydroxide","Aluminium hydroxide gel, dried","Aluminum hydroxide","Dried aluminum hydroxide gel","NSC-664400"],"crossReferences":{"Wikipedia":["Aluminium_hydroxide"],"drugbank":["DB06723"],"chEBI":["33130"]},"childChemblIds":["CHEMBL3833310","CHEMBL3833390"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1983 and has 21 investigational indications."}
{"id":"CHEMBL1200885","canonicalSmiles":"Cc1[nH]cnc1CN1CCc2c(c3ccccc3n2C)C1=O.Cl","inchiKey":"FNYQZOVOVDSGJH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"ALOSETRON HYDROCHLORIDE","yearOfFirstApproval":2000,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1110","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Alosetron hydrochloride","Lotronex"],"synonyms":["Alosetron hcl","Alosetron hydrochloride","GR 68755C","GR-68755C","Lotrpnex"],"crossReferences":{"DailyMed":["alosetron%20hydrochloride"],"PubChem":["144206078","170465416","49681825"],"chEBI":["53783"]},"linkedTargets":{"rows":["ENSG00000166736"],"count":1},"linkedDiseases":{"rows":["EFO_0000555"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2000 and is indicated for irritable bowel syndrome. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1200941","canonicalSmiles":"Cc1ncc(C[n+]2csc(CCO)c2C)c(N)n1.Cl.[Cl-]","inchiKey":"DPJRMOMPQZCRJU-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"THIAMINE HYDROCHLORIDE","maximumClinicalTrialPhase":4,"parentId":"CHEMBL1547","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Benerva","Betalin s","Bevitine","Bevitol","Thiamine hydrochloride","Tyvera","Vit b1","Vit b1 thiamin"],"synonyms":["Aneurine hydrochloride","Betamin","Clotiamina","Eskaphen","FEMA NO. 3322","NSC-36226","Thiamine Disulfide","Thiamine chloride hydrochloride","Thiamine chloride, hydrochloride","Thiamine hcl","Thiamine hydrochloride","Thiamini hydrochloridum","Thiaminum hydrochloricum","Thymine hydrochloride","Vitamin b1"],"crossReferences":{"DailyMed":["thiamine%20hydrochloride"],"PubChem":["11112929","144204287","56320769","56320770"],"chEBI":["49105"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for iron deficiency anemia and anemia (phenotype) and has 2 investigational indications."}
{"id":"CHEMBL1200945","canonicalSmiles":"O=C([O-])CN(CCN(CC(=O)[O-])CC(=O)[O-])CCN(CC(=O)[O-])CC(=O)[O-].[Ca+2].[Na+].[Na+].[Na+]","inchiKey":"AYFCVLSUPGCQKD-UHFFFAOYSA-I","drugType":"Small molecule","blackBoxWarning":true,"name":"PENTETATE CALCIUM TRISODIUM","yearOfFirstApproval":2004,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL780","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Pentetate calcium trisodium"],"synonyms":["Calcium trisodium dtpa","Calcium trisodium pentetate","NSC-34249","Pentetate calcium trisodium"],"crossReferences":{"DailyMed":["pentetate%20calcium%20trisodium"],"DrugCentral":["4753"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2004 and is indicated for pulmonary embolism and has 2 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1200968","canonicalSmiles":"C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)COP(=O)([O-])[O-].[Na+].[Na+]","inchiKey":"RYJIRNNXCHOUTQ-OJJGEMKLSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"HYDROCORTISONE SODIUM PHOSPHATE","yearOfFirstApproval":1960,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1641","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Efcortesol","Hydrocortone"],"synonyms":["Cortisol 21-(disodium phosphate)","Hydrocortisone sodium phosphate"],"crossReferences":{"PubChem":["144206021"],"chEBI":["5781"]},"linkedTargets":{"rows":["ENSG00000113580"],"count":1},"linkedDiseases":{"rows":["EFO_0009552","EFO_0005752","HP_0004798"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1960 and is indicated for eye inflammation and hemorrhoid."}
{"id":"CHEMBL1201060","canonicalSmiles":"CN1CCN(C2=Nc3ccccc3Oc3ccc(Cl)cc32)CC1.Cl","inchiKey":"JSXBVMKACNEMKY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LOXAPINE HYDROCHLORIDE","yearOfFirstApproval":1976,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL831","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Loxitane c","Loxitane im"],"synonyms":["Loxapine hcl","Loxapine hydrochloride"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1976."}
{"id":"CHEMBL1201156","canonicalSmiles":"CNCCC=C1c2ccccc2CCc2ccccc21.Cl","inchiKey":"SHAYBENGXDALFF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"NORTRIPTYLINE HYDROCHLORIDE","yearOfFirstApproval":1964,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL445","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Aventyl","Aventyl hydrochloride","Nortriptyline hydrochloride","Pamelor","Psychostyl"],"synonyms":["38489","NSC-169453","Nortriptyline hcl","Nortriptyline hydrochloride"],"crossReferences":{"DailyMed":["nortriptyline%20hydrochloride"],"PubChem":["144203599","50106715","50106716","562776","56423135","855575"]},"linkedTargets":{"rows":["ENSG00000108576","ENSG00000103546"],"count":2},"linkedDiseases":{"rows":["EFO_0008524","EFO_0000676","EFO_0003761","EFO_0000274","EFO_1000948"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1964 and is indicated for unipolar depression and has 4 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1201208","canonicalSmiles":"CC1NCCOC1c1ccccc1","inchiKey":"OOBHFESNSZDWIU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHENMETRAZINE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Phenmetrazine","Preludin","Trans-phenmetrazine"],"crossReferences":{"Wikipedia":["Phenmetrazine"],"drugbank":["DB00830"],"chEBI":["8067"]},"childChemblIds":["CHEMBL1200483"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL1201220","canonicalSmiles":"CC(=O)Nc1c(I)c(NC(C)=O)c(I)c(C(=O)O)c1I","inchiKey":"YVPYQUNUQOZFHG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIATRIZOIC ACID","yearOfFirstApproval":1954,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Acidum amidotrizoicum","Acidum amidotrizoicum, anhydrous","Amidotrizoic acid","Amidotrizoic acid, anhydrous","Diatrizoate","Diatrizoic acid","NSC-262168","Odiston","Urografin acid","Urogranoic acid","Urotrast"],"crossReferences":{"DailyMed":["diatrizoate%20meglumine","diatrizoate%20sodium"],"PubChem":["144212246"],"Wikipedia":["Diatrizoic_acid"],"drugbank":["DB00271"],"chEBI":["53691"]},"childChemblIds":["CHEMBL3188504","CHEMBL1200581","CHEMBL1534228","CHEMBL2106216","CHEMBL1200839"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1954 and has 1 investigational indication."}
{"id":"CHEMBL1206690","canonicalSmiles":"CCC(=O)NS(=O)(=O)c1ccc(-c2c(-c3ccccc3)noc2C)cc1","inchiKey":"TZRHLKRLEZJVIJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PARECOXIB","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Parecoxib","Rayzon","SC-69124","Xapit"],"crossReferences":{"Wikipedia":["Parecoxib"],"drugbank":["DB08439"],"chEBI":["73038"]},"childChemblIds":["CHEMBL296913"],"linkedTargets":{"rows":["ENSG00000073756"],"count":1},"linkedDiseases":{"rows":["EFO_1001412","EFO_1000218","EFO_0003931","HP_0030834","EFO_1002012","EFO_0003843","MONDO_0005178","EFO_0005755","EFO_1000635"],"count":9},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for rheumatic disease and has 5 investigational indications."}
{"id":"CHEMBL1229950","canonicalSmiles":"C=CCc1ccccc1O","inchiKey":"QIRNGVVZBINFMX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"2-ALLYLPHENOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2-Allylphenol"],"crossReferences":{"PubChem":["144212373"],"drugbank":["DB02534"],"chEBI":["39826"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1230165","canonicalSmiles":"O=C(O)c1ccc2c(c1)nc(Nc1cccc(Cl)c1)c1ccncc12","inchiKey":"MUOKSQABCJCOPU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SILMITASERTIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CX 4945","CX-4945","CX4945","Cx-4945","Cx-4945 free acid","Silmitasertib"],"crossReferences":{"PubChem":["137276036"],"drugbank":["DB15408"]},"linkedTargets":{"rows":["ENSG00000101266"],"count":1},"linkedDiseases":{"rows":["MONDO_0100096","EFO_0002939","EFO_0001378","EFO_0004193","EFO_0005221"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL1230790","canonicalSmiles":"CC(C)n1nc(-c2cccc(O)c2)c2c(N)ncnc21","inchiKey":"MWYBBCLGEHZSCP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1230790","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07335"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1233401","canonicalSmiles":"CCCCCCCc1cc(O)c2ccccc2[n+]1[O-]","inchiKey":"NZPACTGCRWDXCJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1233401","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07918"],"chEBI":["28362"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1233515","canonicalSmiles":"C[C@H]1O[C@H](O[C@@H]2[C@@H](CO)O[C@H](OC[C@H]3O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]3O)[C@H](O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1N[C@H]1C=C(CO)[C@@H](O)[C@H](O)[C@H]1O","inchiKey":"FZLCJZILHGFQLM-PISLJJGOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1233515","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03495"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1236924","canonicalSmiles":"O=S(=O)(Nc1cc(Cl)c(Oc2cnc3ccccc3c2)c(Cl)c1)c1ccc(Cl)cc1Cl","inchiKey":"NMRWDFUZLLQSBN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"INT131","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AMG-131","CHS-131","INT-131","Ibrigampar","Int131","T-0903131","T0903131","T131"],"crossReferences":{"drugbank":["DB05490"]},"linkedTargets":{"rows":["ENSG00000132170"],"count":1},"linkedDiseases":{"rows":["EFO_0003929","MONDO_0005148"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1256818","canonicalSmiles":"Br.COc1ccc2c(c1)[C@]13CCCC[C@@H]1[C@H](C2)N(C)CC3.O","inchiKey":"STTADZBLEUMJRG-IKNOHUQMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DEXTROMETHORPHAN HYDROBROMIDE","yearOfFirstApproval":1984,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL52440","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Beecham coughcaps","Benylin dm","Brontyl","Contac coughcaps","Delsym","Dextromethorphan hydrobromide oros tablets","Drixoral cough","Franolyn dry","Franolyn sed","Pediacare 1","Romilar","Tussabron","Tuxium"],"synonyms":["Dextromethorphan Hydrobromide Monohydrate","Dextromethorphan hydrobromide","NSC-756723"],"crossReferences":{"DailyMed":["dextromethorphan%20hydrobromide"],"PubChem":["11112982","26732619","49731998"]},"linkedTargets":{"rows":["ENSG00000183454","ENSG00000147955"],"count":2},"linkedDiseases":{"rows":["EFO_0000616","EFO_0007486","HP_0012735","MONDO_0002009","HP_0001945","MONDO_0005271","HP_0001742","EFO_0003843","HP_0002315","EFO_0007214","EFO_0001663","MONDO_0005277","MONDO_0002050","EFO_0000544","EFO_0009321","MONDO_0005148","HP_0000737"],"count":17},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1984 and has 7 approved and 7 investigational indications."}
{"id":"CHEMBL134920","canonicalSmiles":"Cn1c([N+](=O)[O-])cnc1/C=C/c1ccnc(N)n1","inchiKey":"LHIALLMPKJMSIQ-NSCUHMNNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AZANIDAZOLE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Azanidazole"],"crossReferences":{"Wikipedia":["Azanidazole"],"drugbank":["DB13350"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1382627","canonicalSmiles":"Nc1ccc(S(=O)(=O)[N-]c2ncccn2)cc1.[Ag+]","inchiKey":"UEJSSZHHYBHCEL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SULFADIAZINE, SILVER","yearOfFirstApproval":1973,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL439","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Flamazine","Flammacerium","Sildaflo","Silvadene","Ssd af","Thermazene"],"synonyms":["Altreet-ag","Dermazin","Silvazine","Silver sulfadiazine","Silver sulphadiazine","Sulfadiazine silver","Sulfadiazine silver salt","Sulfadiazine, silver","Sulfadiazinum argentum"],"crossReferences":{"DailyMed":["silver%20sulfadiazine"],"DrugCentral":["4142"],"PubChem":["124894330","144206550","144207020","8139967"],"drugbank":["DB05245"],"chEBI":["9142"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1973 and has 3 investigational indications."}
{"id":"CHEMBL1398657","canonicalSmiles":"O=S(=O)(O)c1ccc(O)cc1","inchiKey":"FEPBITJSIHRMRT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHENOLSULFONIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["4-phenolsulfonic acid","NSC-227908","P-hydroxybenzenesulfonic acid","P-phenolsulfonate","P-phenolsulfonic acid","Para-phenolsulfonic acid","Phenol-4-sulfonic acid","Phenolsulfonic acid","Sulfocarbolic acid"],"crossReferences":{"PubChem":["144205718","170465916","26757953"],"drugbank":["DB14739"],"chEBI":["32354"]},"childChemblIds":["CHEMBL3989534"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL142348","canonicalSmiles":"C[C@@]12C=CC[C@H]1[C@@H]1CC[C@H]3C[C@H](O)CC[C@]3(C)[C@H]1CC2","inchiKey":"KRVXMNNRSSQZJP-PHFHYRSDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ANDROSTENOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Androstenol"],"crossReferences":{"PubChem":["26756468"],"Wikipedia":["Androstenol"],"drugbank":["DB01889"],"chEBI":["40933"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL142996","canonicalSmiles":"N#C/C(C(=O)Nc1ccc(-c2ccccc2)cc1)=C(/O)C1CC1","inchiKey":"CAGGGMPTWTUYHZ-ZCXUNETKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL142996","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08169"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1451633","canonicalSmiles":"O=C(OCCOCCO)c1ccccc1Nc1cccc(C(F)(F)F)c1","inchiKey":"XILVEPYQJIOVNB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ETOFENAMATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BAY D 1107","BAY-D-1107","BAYD-1107","Etofenamate","TVX-485","TVX485","WHR-5020"],"crossReferences":{"PubChem":["11112716","144204169","170466266"],"drugbank":["DB08984"]},"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL146245","canonicalSmiles":"CC(=O)OC1N=C(c2ccccc2)c2cc(Cl)ccc2NC1=O","inchiKey":"FYRWUTOZBRWYCS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL146245","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB14672"]},"childChemblIds":["CHEMBL3251469"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1473","canonicalSmiles":"CCC(=O)O[C@]1(C(=O)SCF)[C@H](C)C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C","inchiKey":"WMWTYOKRWGGJOA-CENSZEJFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FLUTICASONE PROPIONATE","yearOfFirstApproval":1990,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Aerivio spiromax","Airflusal forspiro","Armonair digihaler","Armonair respiclick","Cutivate","Flixonase","Flixotide","Flonase","Flonase allergy relief","Flovent","Flovent diskus 100","Flovent diskus 250","Flovent diskus 50","Flovent hfa","Fluticasone propionate","Flutiform","Nasofan","Pirinase","Sereflo","Seretide 100","Seretide 125","Seretide 250","Seretide 50","Seretide 500","Sirdupla","Xhance"],"synonyms":["CCI 18781","CCI-18781","FLOVENT","Fluticaps","Fluticasone","Fluticasone propionate","Fluticasone propionate ","Fluticasone-17-propionate","NSC-759889","Opn-375","Optinose","PF-00241939","R01AD08"],"crossReferences":{"DailyMed":["fluticasone%20propionate"],"Wikipedia":["Fluticasone_propionate"],"drugbank":["DB00588"],"chEBI":["31441"]},"linkedTargets":{"rows":["ENSG00000113580"],"count":1},"linkedDiseases":{"rows":["EFO_0007486","EFO_0007183","EFO_0000464","EFO_0010638","MONDO_0005271","EFO_0009536","EFO_0000274","HP_0011950","HP_0100582","EFO_0000676","EFO_0004208","EFO_1001417","EFO_0000400","EFO_0005854","EFO_0008521","EFO_0000701","EFO_1000024","EFO_0000662","HP_0001742","EFO_1001942","HP_0010307","EFO_0004232","EFO_0007227","HP_0006536","MONDO_0100096","EFO_1000391","EFO_0006505","MONDO_0004979","EFO_0000341","HP_0025428","EFO_0007141","EFO_0003918","EFO_0003956"],"count":33},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1990 and has 12 approved and 15 investigational indications."}
{"id":"CHEMBL1520188","canonicalSmiles":"O=P([O-])(O)C(Cl)(Cl)P(=O)([O-])O.[Na+].[Na+]","inchiKey":"HJKBJIYDJLVSAO-UHFFFAOYSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"CLODRONATE DISODIUM","maximumClinicalTrialPhase":3,"parentId":"CHEMBL12318","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Bonefos"],"synonyms":["177501","Clodronate disodium","Clodronate disodium anhydrous","Clodronate disodium tetrahydrate","Clodronic acid disodium salt","Clodronic acid disodium salt anhydrous","Disodium clodronate","Sodium clodronate hydrate","ZK 00091106","ZK-00091106"],"crossReferences":{"PubChem":["11112020","144203860","50106170","85231300"],"chEBI":["59586"]},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1641","canonicalSmiles":"C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)COP(=O)(O)O","inchiKey":"BGSOJVFOEQLVMH-VWUMJDOOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HYDROCORTISONE PHOSPHORIC ACID","yearOfFirstApproval":1960,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Hydrocortisone phosphate"],"crossReferences":{"PubChem":["50112718"],"drugbank":["DB14542"],"chEBI":["68634"]},"childChemblIds":["CHEMBL1200968"],"linkedTargets":{"rows":["ENSG00000113580"],"count":1},"linkedDiseases":{"rows":["EFO_0009552","EFO_0005752","HP_0004798"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1960 and is indicated for eye inflammation and hemorrhoid."}
{"id":"CHEMBL1697828","canonicalSmiles":"CCC(Br)(CC)C(=O)NC(N)=O","inchiKey":"OPNPQXLQERQBBV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CARBROMAL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Adalin"],"synonyms":["2-bromo-2-ethylbutyryurea","Bromodiethylacetylurea","Carbromal","NSC-49191"],"crossReferences":{"PubChem":["144212564"],"Wikipedia":["Carbromal"],"drugbank":["DB13817"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1697832","canonicalSmiles":"C[C@]12C[C@H](O)[C@H]3[C@@H](C=C(Cl)C4=CC(=O)C=C[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)CO","inchiKey":"YTJIBEDMAQUYSZ-FDNPDPBUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CLOPREDNOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Cloradryn"],"synonyms":["Cloprednol","RS-4691"],"crossReferences":{"drugbank":["DB13843"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL173373","canonicalSmiles":"CCOC(=O)C(C)=O","inchiKey":"XXRCUYVCPSWGCC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ETHYL PYRUVATE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2-Oxo-Propionic Acid Ethyl Ester","CTI-01","Ethyl pyruvate","FEMA NO. 2457","NSC-48386","Pyruvic acid ethyl ester","Pyruvic acid, ethyl ester"],"crossReferences":{"drugbank":["DB05869"]},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL1740071","canonicalSmiles":"C[n+]1ccc(C(=O)NCc2ccccc2)cc1","inchiKey":"QOEJDHLJOKRPJG-UHFFFAOYSA-O","drugType":"Small molecule","blackBoxWarning":false,"name":"ENISAMIUM","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Enisamium cation","Enisamium ion"],"childChemblIds":["CHEMBL1716983"],"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL1741","canonicalSmiles":"CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O","inchiKey":"AGOYDEPGAOXOCK-KCBOHYOISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CLARITHROMYCIN","yearOfFirstApproval":1991,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Biaxin","Biaxin Xl Pac","Biaxin xl","Clarie xl","Clarithromycin","Clarithromycin Extended Release","Clarosip","Febzin xl","Klaricid","Klaricid 500","Klaricid adult","Klaricid i.v.","Klaricid paed","Klaricid xl","Mycifor xl","Xetinin xl","Zeclar"],"synonyms":["6-o-methylerythromycin","A-56268","ABBOTT-56268","Biaxin","Clarithromycin","Clarithromycin identity","Cyllind","Erythromycin, 6-o-methyl-","Klacid","Macladin","Mavid","NSC-758704","Prevpac","TE-031","Veclam"],"crossReferences":{"DailyMed":["clarithromycin"],"PubChem":["26719890","49648843"],"drugbank":["DB01211"],"chEBI":["3732"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1991 and has 10 approved and 41 investigational indications."}
{"id":"CHEMBL1768","canonicalSmiles":"CC(C[N+](C)(C)C)OC(N)=O.[Cl-]","inchiKey":"XXRMYXBSBOVVBH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BETHANECHOL CHLORIDE","yearOfFirstApproval":1948,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1482","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Bethanechol chloride","Duvoid","Myocholine","Myotonachol","Myotonine","Urecholine"],"synonyms":["Bethanechol Chloride","Bethanechol chloride","Carbamylmethylcholine chloride","NSC-30783"],"crossReferences":{"DailyMed":["bethanechol%20chloride"],"PubChem":["144205581","26747481","50106064","56422417","855684"],"chEBI":["3085"]},"linkedTargets":{"rows":["ENSG00000133019","ENSG00000181072"],"count":2},"linkedDiseases":{"rows":["HP_0000016"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1948 and is indicated for urinary retention."}
{"id":"CHEMBL178654","canonicalSmiles":"CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4cccc(F)c4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C","inchiKey":"NERXPXBELDBEPZ-RMKNXTFCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HKI-357","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Hki-357"],"crossReferences":{"drugbank":["DB13002"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1788404","canonicalSmiles":"C[N+](C)(CCOc1ccccc1)Cc1ccccc1","inchiKey":"AVWWVJUMXRXPNF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BEPHENIUM","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bephenium"],"crossReferences":{"drugbank":["DB13462"]},"childChemblIds":["CHEMBL3391735"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1789843","drugType":"Antibody","blackBoxWarning":false,"name":"BELIMUMAB","yearOfFirstApproval":2011,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Benlysta","Lymphostat-b","Lymphostat-b benlysta"],"synonyms":["BEL-114333","BEL114333","Belimumab","Belimumab (genetical recombination)","GSK-1550188","GSK1550188","HGS-1006","HGS1006"],"crossReferences":{"DailyMed":["belimumab"],"DrugCentral":["4949"]},"linkedTargets":{"rows":["ENSG00000102524"],"count":1},"linkedDiseases":{"rows":["EFO_0002689","MONDO_0013730","EFO_0000685","EFO_0005761","EFO_0000464","EFO_0000540","EFO_0006803","EFO_0007160","EFO_0004254","EFO_0002690","MONDO_0005301","EFO_0000095","MONDO_0017287","EFO_0000783","EFO_0004255","EFO_0004256","EFO_0000717","EFO_0000699"],"count":18},"description":"Antibody drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2011 and has 3 approved and 11 investigational indications."}
{"id":"CHEMBL184151","canonicalSmiles":"N#CCc1cc(O)cc2cc(-c3ccc(O)cc3)oc12","inchiKey":"ZKJVCUXZMYKTLT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL184151","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB06927"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL186422","canonicalSmiles":"O=c1ccc2ccccc2[nH]1","inchiKey":"LISFMEBWQUVKPJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"2-Hydroxyquinoline","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2-Hydroxyquinoline","Quinolin-2-ol"],"crossReferences":{"PubChem":["29217777"],"drugbank":["DB04745"],"chEBI":["16365"]},"childChemblIds":["CHEMBL1673272"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL191146","canonicalSmiles":"CCCc1c(SC2CCCCC2)c2cc(Cl)ccc2[nH]c1=O","inchiKey":"CLKFNGKDJYMUPK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL191146","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07868"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2103741","canonicalSmiles":"N[C@@H](Cc1cc(I)c(Oc2cc(I)c(O)c(I)c2)c(I)c1)C(=O)[O-].O.[Na+]","inchiKey":"ANMYAHDLKVNJJO-LTCKWSDVSA-M","drugType":"Small molecule","blackBoxWarning":true,"name":"LEVOTHYROXINE SODIUM","yearOfFirstApproval":2000,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1624","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Eltroxin","Euthyrox","Evotrox","L-thyroxine henning","Levo-t","Levolet","Levothroid","Levothyroid","Levothyroxine sodium","Levoxine","Levoxyl","Novothyrox","Soloxine","Synthroid","Thyquidity","Thyro-tabs","Thyrol L","Thyroxine","Tirosint","Tirosint-sol","Unithroid"],"synonyms":["Eferox","Levaxin","Levothyrox","Levothyroxine sodium","Levothyroxine sodium anhydrous","Levothyroxine sodium hydrate","Liotrix (t4)","Monosodium l-thyroxine hydrate","NSC-259940","Oroxine","Soloxine","T4","T4 (liotrix)","Thyroxine","Thyroxine sodium","Thyroxine sodium salt"],"crossReferences":{"DailyMed":["levothyroxine%20sodium"],"chEBI":["6447"]},"linkedTargets":{"rows":["ENSG00000126351","ENSG00000151090"],"count":2},"linkedDiseases":{"rows":["EFO_0006859","Orphanet_442","EFO_0000289","EFO_0002892","MONDO_0002108","EFO_1001062","EFO_1002017","EFO_0003843","EFO_0004705"],"count":9},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2000 and has 5 approved and 2 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL2103880","canonicalSmiles":"CN(C)CCCOc1ccc2[nH]nc(S(=O)(=O)c3cccc4ccccc34)c2c1","inchiKey":"NXQGEDVQXVTCDA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CERLAPIRDINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cerlapirdine","PF-05212365","SAM-531","SAM-531 FREE BASE","Sam-531","WAY-262,531","WAY-262531"],"crossReferences":{"drugbank":["DB12229"]},"childChemblIds":["CHEMBL2105752"],"linkedTargets":{"rows":["ENSG00000158748"],"count":1},"linkedDiseases":{"rows":["MONDO_0004975"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2103920","canonicalSmiles":"CC[C@H](C)[C@@H]1NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)CNC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]2CCCN2C(=O)[C@H](C)NC(=O)[C@@H](N)[C@@H](C)O)CSSC[C@@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)O)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)CNC1=O","inchiKey":"IUCCYQIEZNQWRS-DWWHXVEHSA-N","drugType":"Protein","blackBoxWarning":false,"name":"ULARITIDE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ularitide","Urodilatin","Urodilatin ularitide"],"crossReferences":{"drugbank":["DB05034"]},"description":"Protein drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2104207","canonicalSmiles":"CC(NCCn1cnc2c1c(=O)n(C)c(=O)n2C)C(O)c1ccccc1","inchiKey":"UJSKUDDDPKGBJY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CAFEDRINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(-)-cafedrine","Cafedrine","Norephendrinetheophylline"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2104262","canonicalSmiles":"Oc1ccc2c(c1)C(Cc1c[nH]cn1)CC2","inchiKey":"VTZPAJGVRWKMAG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FADOLMIDINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Fadolmidine","Radolmidine"],"childChemblIds":["CHEMBL2106710"],"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL2105804","canonicalSmiles":"Cc1cc(C)c2c3ccccc3n(Cc3cccc([C@@H](C(=O)N[C@@H](CO)c4ccccc4)C4CCCC4)c3)c2n1","inchiKey":"AMNXBQPRODZJQR-DITALETJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IMPLITAPIDE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BAY-13-9952","Implitapide"],"crossReferences":{"drugbank":["DB04852"]},"linkedTargets":{"rows":["ENSG00000138823","ENSG00000185624"],"count":2},"linkedDiseases":{"rows":["EFO_0004211","EFO_0004911"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2106265","canonicalSmiles":"CC(C=C(c1cccs1)c1cccs1)N(C)C","inchiKey":"CANBGVXYBPOLRR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIMETHYLTHIAMBUTENE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Acscn-9619","Dimethibutin","Dimethylthiambutene","IDS-ND-014","Kobaton","Nih-4542","Ohton","Takaton"],"crossReferences":{"drugbank":["DB01444"],"chEBI":["59781"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2107819","canonicalSmiles":"CCO[C@@H]1OC(=O)C[C@@H]1NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)c1ccc(N)c(Cl)c1)C(C)(C)C","inchiKey":"SJDDOCKBXFJEJB-MOKWFATOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BELNACASAN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Vx-765"],"synonyms":["Belnacasan","VX-765"],"linkedTargets":{"rows":["ENSG00000137752"],"count":1},"linkedDiseases":{"rows":["EFO_0000474","MONDO_0100096","EFO_0004263","EFO_0000676"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2107867","drugType":"Cell","blackBoxWarning":false,"name":"CENPLACEL-L","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cenplacel","Cenplacel-l","PDA-001","PDA001"],"description":"Cell drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2108119","drugType":"Antibody","blackBoxWarning":false,"name":"PASCOLIZUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ANTI-IL4","Anti-il-4 antibody","Pascolizumab","SB-240683"],"linkedTargets":{"rows":["ENSG00000113520"],"count":1},"linkedDiseases":{"rows":["Orphanet_3389","MONDO_0004979"],"count":2},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2108171","drugType":"Oligonucleotide","blackBoxWarning":false,"name":"ABETIMUS","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Abetimus"],"description":"Oligonucleotide drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2109056","drugType":"Unknown","blackBoxWarning":false,"name":"ECHINACEA PURPUREA, POWDERED","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Echinacea purpurea, powdered"],"description":"Unknown drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2109212","drugType":"Protein","blackBoxWarning":false,"name":"PROINSULIN HUMAN","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LY-167005","LY167005","Proinsulin","Proinsulin biosynthetic human","Proinsulin human","Proinsulin recombinant human","Recombinant human proinsulin"],"description":"Protein drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2109519","drugType":"Antibody","blackBoxWarning":false,"name":"ABX-MA1","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ABX-MA1"],"description":"Antibody drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2109575","drugType":"Antibody","blackBoxWarning":false,"name":"BIIB-015","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BIIB-015","Biib-015"],"linkedTargets":{"rows":["ENSG00000241186"],"count":1},"linkedDiseases":{"rows":["EFO_0000616"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2109591","drugType":"Antibody","blackBoxWarning":false,"name":"TOL-101","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["TOL-101","TOL101","Tol-101"],"linkedTargets":{"rows":["ENSG00000211699","ENSG00000277734","ENSG00000278030","ENSG00000211810"],"count":4},"linkedDiseases":{"rows":["EFO_0003884"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2110627","canonicalSmiles":"CCOC(=O)[C@H](CCc1ccccc1)N[C@H]1CS[C@H](c2cccs2)CN(CC(=O)O)C1=O","inchiKey":"FIQOFIRCTOWDOW-BJLQDIEVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TEMOCAPRIL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Temocapril"],"crossReferences":{"drugbank":["DB08836"]},"childChemblIds":["CHEMBL2104499"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2111076","canonicalSmiles":"CC(N)CCCC(C)(C)O","inchiKey":"LREQLEBVOXIEOM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HEPTAMINOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["6-hydroxy-6-methyl-2-heptamine","Corasore","Ginkor","Heptaminol"],"crossReferences":{"drugbank":["DB13574"]},"childChemblIds":["CHEMBL2107282"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2142592","canonicalSmiles":"CN(C(=O)c1ccc(F)cc1C(F)(F)F)C1CCN(c2nnc(-c3ccnn3C)c3ccccc23)CC1","inchiKey":"SZBGQDXLNMELTB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TALADEGIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LY-2940680","LY2940680","Taladegib"],"crossReferences":{"PubChem":["137276014"],"drugbank":["DB12550"]},"linkedTargets":{"rows":["ENSG00000128602"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_0000768","EFO_0000702","EFO_0000311","EFO_0009708"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL218289","canonicalSmiles":"C[C@H](CCc1ccc(C(N)=O)cc1)NCC(=O)c1ccc(F)cc1","inchiKey":"OIWWNWQZJJKBTR-CYBMUJFWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL218289","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08672"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2221249","canonicalSmiles":"CC(C)CCCCC(=O)N[C@@H](CCN)C(=O)N[C@@H](CN[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CCN)NC1=O)[C@@H](C)O.CCC(C)CCCCC(=O)N[C@@H](CCN)C(=O)N[C@@H](CN[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CCN)NC1=O)[C@@H](C)O","inchiKey":"JORAUNFTUVJTNG-BSTBCYLQSA-N","drugType":"Protein","blackBoxWarning":false,"name":"COLISTIN","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Colistin","Polymyxin E"],"crossReferences":{"DrugCentral":["4425"]},"childChemblIds":["CHEMBL2218908"],"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) and is indicated for bacterial disease and has 8 investigational indications."}
{"id":"CHEMBL222838","canonicalSmiles":"NCCC[C@](N)(C(=O)O)C(F)F","inchiKey":"VLCYCQAOQCDTCN-ZCFIWIBFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"L-EFLORNITHINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["L-Eflornithine"],"crossReferences":{"drugbank":["DB03856"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2361641","canonicalSmiles":"CO[C@H]1C[C@H](O[C@H]2[C@H](C)O[C@@H](O[C@@H]3/C(C)=C/C[C@@H]4C[C@@H](C[C@]5(C=C[C@H](C)[C@@H](C6CCCCC6)O5)O4)OC(=O)[C@@H]4C=C(C)[C@@H](O)[C@H]5OC/C(=C\\C=C\\[C@@H]3C)[C@@]45O)C[C@@H]2OC)O[C@@H](C)[C@@H]1O","inchiKey":"QLFZZSKTJWDQOS-YDBLARSUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DORAMECTIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dectomax","Doramectin","L 701023","L-701023","NSC-760342","UK 67994","UK-67,994","UK-67994"],"crossReferences":{"PubChem":["144206992"],"drugbank":["DB11400"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2364607","canonicalSmiles":"O=C(O)/C=C/C(=O)O.O=C(c1ccc(F)c(F)c1Nc1ccc(I)cc1F)N1CC(O)([C@@H]2CCCCN2)C1.O=C(c1ccc(F)c(F)c1Nc1ccc(I)cc1F)N1CC(O)([C@@H]2CCCCN2)C1","inchiKey":"RESIMIUSNACMNW-BXRWSSRYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"COBIMETINIB FUMARATE","yearOfFirstApproval":2015,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL2146883","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cotellic"],"synonyms":["Cobimetinib fumarate","Cobimetinib hemifumarate","Gdc-0973 hemifumarate","Xl-518 hemifumarate"],"crossReferences":{"DailyMed":["cobimetinib%20fumarate"]},"linkedTargets":{"rows":["ENSG00000126934","ENSG00000169032"],"count":2},"linkedDiseases":{"rows":["EFO_0002617"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2015 and is indicated for metastatic melanoma."}
{"id":"CHEMBL2374220","canonicalSmiles":"COC(=O)N[C@H](C(=O)N1CC2(CC2)C[C@H]1c1nc(-c2ccc3c(c2)C(F)(F)c2cc(-c4ccc5[nH]c([C@@H]6[C@H]7CC[C@H](C7)N6C(=O)[C@@H](NC(=O)OC)C(C)C)nc5c4)ccc2-3)c[nH]1)C(C)C","inchiKey":"VRTWBAAJJOHBQU-KMWAZVGDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LEDIPASVIR","yearOfFirstApproval":2014,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["GS-5885","Ledipasvir","Ledipasvir acetonate"],"crossReferences":{"DailyMed":["ledipasvir"],"drugbank":["DB09027"],"chEBI":["85089"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2014 and is indicated for chronic hepatitis c virus infection and hepatitis c virus infection and has 4 investigational indications."}
{"id":"CHEMBL258208","canonicalSmiles":"O=P(O)(O)OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)COP(=O)(O)O","inchiKey":"WOYYTQHMNDWRCW-KVTDHHQDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"Mannitol Bis-Phosphate","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Mannitol Bis-Phosphate"],"crossReferences":{"drugbank":["DB04733"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL261772","canonicalSmiles":"C=C1c2c(Cl)ccc(O)c2C(=O)C2=C(O)[C@]3(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]3[C@@H](O)[C@H]12.O=C(O)c1cc(S(=O)(=O)O)ccc1O","inchiKey":"FYSVKUUNXYGFLA-CCHMMTNSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MECLOCYCLINE SULFOSALICYLATE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Meclan","Meclocil","Mecloderm","Meclosorb","Quoderm","Traumatociclina"],"synonyms":["Meclocycline 5-sulfosalicylate","Meclocycline sulfosalicylate","Meclocyline sulfosalicylate","NSC-757831","SNX-1012"],"crossReferences":{"PubChem":["144204345"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1982 and has 2 investigational indications."}
{"id":"CHEMBL265720","canonicalSmiles":"c1ccc(-c2cc(-c3cc[nH]n3)on2)cc1","inchiKey":"SRSSTOPJERVMRZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL265720","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07613"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL272080","canonicalSmiles":"CN[C@@H]1[C@@H](O)[C@@H](O[C@@H]2[C@@H](O)[C@H](O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3O)[C@@H](N)C[C@H]2NC(=O)[C@@H](O)CN)OC[C@]1(C)O","inchiKey":"UDIIBEDMEYAVNG-ZKFPOVNWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ISEPAMICIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Hapa-b","Isepamicin","Isepamicin sulfate","SCH 21420","SCH-21420"],"crossReferences":{"Wikipedia":["Isepamicin"],"drugbank":["DB13540"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL290106","canonicalSmiles":"Oc1c(Cl)cc(Cl)cc1Sc1cc(Cl)cc(Cl)c1O","inchiKey":"JFIOVJDNOJYLKP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BITHIONOL","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United States"],"classes":["Dermatological toxicity"],"year":1967},"tradeNames":["Lorothidol"],"synonyms":["Bithin","Bithionol","NSC-47129"],"crossReferences":{"PubChem":["104171365","144204383","144207582","144213236","170465515","17389712","26751444","50100878","50123605","855531","99234233"],"Wikipedia":["Bithionol"],"drugbank":["DB04813"],"chEBI":["3131"]},"childChemblIds":["CHEMBL1447476"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for helminthiasis and acne. It was withdrawn in United States  in 1967 due to Dermatological toxicity."}
{"id":"CHEMBL291386","canonicalSmiles":"COc1cc(C)c2ccc(O)c(C(=O)O[C@@H]3[C@@H](O)C=C[C@H]3O)c2c1","inchiKey":"XILHLKXLRFUQFI-QLPKVWCKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL291386","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08261"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL296435","canonicalSmiles":"CCCCCC[C@H]([C@H](C)O)n1cnc2c(N)ncnc21","inchiKey":"IOSAAWHGJUZBOG-WDEREUQCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"(+)-EHNA","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07711"],"chEBI":["63059"]},"childChemblIds":["CHEMBL1995433"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL306043","drugType":"Small molecule","blackBoxWarning":false,"name":"GOLD SODIUM THIOMALATE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Myochrysine","Myocrisin"],"synonyms":["Aurothiomalate","Aurothiomalate disodium","Aurothiomalate sodium","Chrysothios","Gold sodium thiomalate","Kidon","Miocrisina","Myochrysin","Shiosol","Sodium aurothiomalate","Tauredon"],"crossReferences":{"DrugCentral":["4706"],"chEBI":["38722"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for rheumatic disease and has 1 investigational indication."}
{"id":"CHEMBL3137744","canonicalSmiles":"OC[C@H](O)[C@H](O)[C@H](O)CO","inchiKey":"HEBKCHPVOIAQTA-ZXFHETKHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3137744","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB14704"],"chEBI":["15963"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3301610","canonicalSmiles":"CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1","inchiKey":"UZWDCWONPYILKI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ABEMACICLIB","yearOfFirstApproval":2017,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Verzenio","Verzenios"],"synonyms":["Abemaciclib","LY-2835219","LY2835219","Ly-2835219"],"crossReferences":{"DailyMed":["abemaciclib"],"drugbank":["DB12001"]},"childChemblIds":["CHEMBL4290012","CHEMBL4560869","CHEMBL4534140","CHEMBL4474565"],"linkedTargets":{"rows":["ENSG00000135446","ENSG00000105810"],"count":2},"linkedDiseases":{"rows":["EFO_0005232","EFO_0003869","EFO_0000637","EFO_0000558","EFO_1001958","MONDO_0100342","EFO_0000756","MONDO_0007254","EFO_1001469","EFO_0005952","EFO_0000305","EFO_0003085","EFO_0000632","EFO_1001951","MONDO_0001187","EFO_0000588","EFO_0003968","EFO_0000389","MONDO_0008903","EFO_1001331","EFO_0000182","EFO_0000673","EFO_0002918","Orphanet_2495","EFO_0000616","EFO_0002618","MONDO_0002108","EFO_0000349","Orphanet_636","EFO_0000313","EFO_0003060","MONDO_0008315","EFO_0000621","EFO_0000311","EFO_0009708","EFO_1000026","EFO_0000304","EFO_0000174","EFO_0005537","EFO_0002517","EFO_0005701","MONDO_0011962","EFO_0004284","EFO_0000574","EFO_0001378","MONDO_0024880","EFO_0003833","EFO_0000519","EFO_0000181","EFO_1000233"],"count":50},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2017 and has 5 approved and 36 investigational indications."}
{"id":"CHEMBL3317856","canonicalSmiles":"O=c1ccc2ncc(=O)n3c2n1C[C@H]3CN1CCC(NCc2cc3c(cn2)OCCC3)CC1","inchiKey":"PZFAZQUREQIODZ-LJQANCHMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GEPOTIDACIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GSK-2140944","GSK2140944","Gepotidacin"],"crossReferences":{"drugbank":["DB12134"]},"childChemblIds":["CHEMBL3545364"],"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL348000","canonicalSmiles":"O=C(O)c1cc(-c2ccccc2)nc2ccccc12","inchiKey":"YTRMTPPVNRALON-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CINCHOPHEN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cinchophen","NSC-2617","Phenylcinchoninic acid"],"crossReferences":{"PubChem":["104171373","124883499","124883501","144204392","144213983","170466318","26751442","4262559","50085459","855522"],"Wikipedia":["Cinchophen"],"drugbank":["DB13551"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3544967","drugType":"Small molecule","blackBoxWarning":false,"name":"GSK-2256098","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Gsk-2256098","Gsk2256098"],"linkedTargets":{"rows":["ENSG00000169398"],"count":1},"linkedDiseases":{"rows":["EFO_0001361","EFO_1000044","Orphanet_2495","EFO_0000311"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL3544984","canonicalSmiles":"O=C(c1ccccc1Cl)c1cccnc1-c1nnn(Cc2cc(C(F)(F)F)cc(C(F)(F)F)c2)c1-c1ccncc1","inchiKey":"CAVRKWRKTNINFF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRADIPITANT","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LY-686017","LY686017","Ly686017","Tradipitant","VLY-686"],"crossReferences":{"drugbank":["DB12580"]},"linkedTargets":{"rows":["ENSG00000115353"],"count":1},"linkedDiseases":{"rows":["EFO_0006928","HP_0000989","MONDO_0100096","EFO_1000948","EFO_0000274","MONDO_0007079","EFO_1001917"],"count":7},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 7 investigational indications."}
{"id":"CHEMBL3545033","drugType":"Small molecule","blackBoxWarning":false,"name":"LY2828360","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LY-2828360","LY2828360","Ly2828360"],"linkedTargets":{"rows":["ENSG00000188822"],"count":1},"linkedDiseases":{"rows":["EFO_0004616"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3545042","canonicalSmiles":"CC(C)c1cc2[nH]c(=O)n(NS(C)(=O)=O)c(=O)c2cc1-c1ccnn1C","inchiKey":"MCECSFFXUPEPDB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SELURAMPANEL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BGG-492","BGG492","Bgg492","Selurampanel"],"crossReferences":{"drugbank":["DB12367"]},"linkedTargets":{"rows":["ENSG00000125675","ENSG00000120251","ENSG00000164418","ENSG00000171189","ENSG00000105737","ENSG00000149403","ENSG00000155511","ENSG00000152578","ENSG00000163873"],"count":9},"linkedDiseases":{"rows":["HP_0001257","MONDO_0005277","HP_0000360","EFO_0000474","MONDO_0005301","MONDO_0015643","HP_0001250"],"count":7},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 7 investigational indications."}
{"id":"CHEMBL3545405","drugType":"Small molecule","blackBoxWarning":false,"name":"BAY1067197","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BAY-10-67197","BAY-1067197","BAY10-67197","BAY1067197","Bay1067197","Neladenoson bialanate","Neladenoson dalanate"],"linkedTargets":{"rows":["ENSG00000163485"],"count":1},"linkedDiseases":{"rows":["EFO_0003144"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL365617","canonicalSmiles":"CCNC(=O)c1n[nH]c(-c2cc(Cl)c(O)cc2O)c1-c1ccc(OC)cc1","inchiKey":"HUNAOTXNHVALTN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VER-49009","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["VER-49009"],"crossReferences":{"PubChem":["103905495"],"drugbank":["DB07495"],"chEBI":["47273"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL376109","canonicalSmiles":"NC[C@@H]1O[C@H](O[C@@H]2[C@@H](CO)O[C@@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3N)[C@@H]2OCCNCC2CCCNC2)[C@H](N)[C@@H](O)[C@@H]1O","inchiKey":"AHJDGUQMOYBKDU-NSCPTEJBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL376109","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04718"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3833327","canonicalSmiles":"CC(=O)Nc1ccc(C(=O)O)cc1.CC(=O)Nc1ccc(C(=O)O)cc1.CC(=O)Nc1ccc(C(=O)O)cc1.CC(O)CN(C)C.CC(O)CN(C)C.CC(O)CN(C)C.O=c1[nH]cnc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O","inchiKey":"YLDCUKJMEKGGFI-QCSRICIXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"INOSINE PRANOBEX","maximumClinicalTrialPhase":4,"parentId":"CHEMBL3833405","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Imunovir"],"synonyms":["Delimmun","Imunoviral","Inosine acedobene dimepranol","Inosine pranobex","Inosiplex","Isoprinosin","Isoprinosina","Isoprinosine","Isoviral","Methisoprinol","Modimmunal","NP-113","NPT-10381","Pranosina","Pranosine","Viruxan"],"crossReferences":{"DrugCentral":["4576"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for viral disease and has 1 investigational indication."}
{"id":"CHEMBL385517","canonicalSmiles":"N#C[C@@H]1C[C@@H]2C[C@@H]2N1C(=O)[C@@H](N)C12CC3CC(CC(O)(C3)C1)C2","inchiKey":"QGJUIPDUBHWZPV-SGTAVMJGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SAXAGLIPTIN","yearOfFirstApproval":2009,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["BMS-477118","BMS-477118-11","Saxagliptin"],"crossReferences":{"DailyMed":["saxagliptin%20hydrochloride"],"PubChem":["144206461"],"Wikipedia":["Saxagliptin"],"drugbank":["DB06335"],"chEBI":["71272"]},"childChemblIds":["CHEMBL2103745","CHEMBL1201743","CHEMBL3542376"],"linkedTargets":{"rows":["ENSG00000197635"],"count":1},"linkedDiseases":{"rows":["EFO_1001459","EFO_1001121","MONDO_0005147","EFO_0008583","MONDO_0005148","EFO_0000400","HP_0012594","EFO_0002546","EFO_0003940","EFO_0000660"],"count":10},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2009 and is indicated for diabetes mellitus and type 2 diabetes mellitus and has 5 investigational indications."}
{"id":"CHEMBL39541","canonicalSmiles":"CC[C@H](C)[C@@H]([C@@H](CC(=O)N1CCC[C@H]1[C@H](OC)[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)c1nccs1)OC)N(C)C(=O)[C@@H](NC(=O)[C@H](C(C)C)N(C)C)C(C)C","inchiKey":"OFDNQWIFNXBECV-VFSYNPLYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DOLASTATIN-10","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dolastatin 10","Dolastatin-10","Dolostatin 10"],"crossReferences":{"drugbank":["DB12730"],"chEBI":["67357"]},"linkedTargets":{"rows":["ENSG00000261456","ENSG00000167553","ENSG00000127824","ENSG00000188229","ENSG00000198033","ENSG00000258947","ENSG00000152086","ENSG00000196230","ENSG00000104833","ENSG00000137267","ENSG00000167552","ENSG00000101162","ENSG00000123416","ENSG00000137285","ENSG00000176014"],"count":15},"linkedDiseases":{"rows":["EFO_0000198","EFO_0000565","EFO_0002618","MONDO_0021321","MONDO_0008170","MONDO_0005411","EFO_0000574","MONDO_0002367","EFO_0000691","MONDO_0008315"],"count":10},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 9 investigational indications."}
{"id":"CHEMBL3989543","canonicalSmiles":"CC[C@]1(O)C[C@@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C)[C@H]3[C@@](O)(C(N)=O)[C@H](O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1.O=S(=O)(O)O","inchiKey":"COFJBSXICYYSKG-OAUVCNBTSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VINDESINE SULFATE","maximumClinicalTrialPhase":4,"parentId":"CHEMBL238071","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Eldisine"],"synonyms":["Fildesin","LY-099094","LY099094","NSC-245467","Vindesine sulfate","Vindesine sulfate salt","Vindesine sulphate"],"description":"Small molecule drug with a maximum clinical trial phase of IV and has 1 investigational indication."}
{"id":"CHEMBL3989658","canonicalSmiles":"CS(=O)(=O)O.Nc1ncnc2c1ncn2CCOC[P@@]1(=O)OCC[C@@H](c2cccc(Cl)c2)O1","inchiKey":"JXQUAHHUSMJUFV-HZPZRMRQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PRADEFOVIR MESYLATE","maximumClinicalTrialPhase":3,"parentId":"CHEMBL2096895","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Pradefovir mesilate","Pradefovir mesylate"],"crossReferences":{"drugbank":["DB05478"]},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL406270","canonicalSmiles":"O[C@@H](CS)[C@@H](O)CS","inchiKey":"VHJLVAABSRFDPM-IMJSIDKUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DITHIOTHREITOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dithiothreitol"],"crossReferences":{"Wikipedia":["Dithiothreitol"],"drugbank":["DB04447"],"chEBI":["42106"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL422668","canonicalSmiles":"NS(=O)(=O)N[C@@H](Cc1ccccc1)C(=O)O","inchiKey":"PHGMHLLGXKQIDY-QMMMGPOBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL422668","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03012"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4297372","drugType":"Small molecule","blackBoxWarning":false,"name":"ATSM COPPER (II)","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Atsm copper (ii)","Cu(ii)atsm","Cu-atsm"],"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297398","canonicalSmiles":"CCCc1c(OCc2ccc([C@H](O)c3cccc(C(=O)O)c3)cc2)ccc(C(C)=O)c1O","inchiKey":"DWQVYDLTPMGYNE-DEOSSOPVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LY-2300559","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LY2300559","Ly-2300559","Ly2300559"],"crossReferences":{"drugbank":["DB13016"]},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297543","canonicalSmiles":"COCCCC(=O)NCc1ccc(C(F)(F)F)cc1","inchiKey":"QLZOWJNFLXSDSH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GET-73","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Get 73","Get-73"],"crossReferences":{"drugbank":["DB12928"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297736","drugType":"Antibody","blackBoxWarning":false,"name":"PRALUZATAMAB RAVTANSINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Anti-cd166-dm4 cx-2009","CX-2009","Cx 2009","Cx-2009","Praluzatamab ravtansine"],"linkedTargets":{"rows":["ENSG00000261456","ENSG00000167553","ENSG00000127824","ENSG00000188229","ENSG00000198033","ENSG00000258947","ENSG00000152086","ENSG00000170017","ENSG00000196230","ENSG00000104833","ENSG00000137267","ENSG00000167552","ENSG00000101162","ENSG00000123416","ENSG00000137285","ENSG00000176014"],"count":16},"linkedDiseases":{"rows":["MONDO_0007254"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297763","drugType":"Unknown","blackBoxWarning":false,"name":"GTI-2040","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Gti 2040","Gti-2040"],"linkedTargets":{"rows":["ENSG00000171848"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_0006861","EFO_0000222","MONDO_0008315"],"count":4},"description":"Unknown drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL4297819","drugType":"Unknown","blackBoxWarning":false,"name":"ROPEGINTERFERON ALFA-2B","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Aop2014","Besremi","P-1101","P1101","Ropeginterferon alfa-2b"],"linkedTargets":{"rows":["ENSG00000159110","ENSG00000142166"],"count":2},"linkedDiseases":{"rows":["EFO_0004220","EFO_0000339","EFO_0000182","EFO_0007304","EFO_0002429","EFO_0004239","EFO_0000479"],"count":7},"description":"Unknown drug with a maximum clinical trial phase of IV (across all indications) and has 7 investigational indications."}
{"id":"CHEMBL4297990","drugType":"Protein","blackBoxWarning":false,"name":"TEBENTAFUSP","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["IMCGP-100","IMCGP100","IMCgp 100","IMMTAC IMCGP100","Imcgp100","ImmTAC IMCgpgp 100","Tebentafusp"],"linkedTargets":{"rows":["ENSG00000185664"],"count":1},"linkedDiseases":{"rows":["EFO_1000616","EFO_0000756"],"count":2},"description":"Protein drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4298072","drugType":"Unknown","blackBoxWarning":false,"name":"MARZEPTACOG ALFA (ACTIVATED)","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cb-813","Marzeptacog alfa (activated)","Marzeptacog alpha","PF-05280602","Pf-05280602"],"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4298204","drugType":"Protein","blackBoxWarning":false,"name":"EFAVALEUKIN ALFA","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AMG 592","AMG-592","Efavaleukin alfa"],"description":"Protein drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL443052","canonicalSmiles":"OB1OCc2cc(F)ccc21","inchiKey":"LFQDNHWZDQTITF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TAVABOROLE","yearOfFirstApproval":2014,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Kerydin"],"synonyms":["AN-2690","AN2690","Tavaborole"],"crossReferences":{"DailyMed":["tavaborole"],"PubChem":["174316125"],"drugbank":["DB09041"],"chEBI":["77942"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2014 and is indicated for tinea."}
{"id":"CHEMBL457","canonicalSmiles":"Cc1ccc(C)c(OCCCC(C)(C)C(=O)O)c1","inchiKey":"HEMJJKBWTPKOJG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GEMFIBROZIL","yearOfFirstApproval":1981,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Emfib","Gemfibrozil","Lopid"],"synonyms":["CI-719","Gemfibrozil","NSC-757024"],"crossReferences":{"DailyMed":["gemfibrozil"],"PubChem":["11112705","144204164","144209195","144213101","170464998","17389870","174007259","26751515","49718189","855780"],"TG-GATEs":["31"],"Wikipedia":["Gemfibrozil"],"drugbank":["DB01241"],"chEBI":["5296"]},"linkedTargets":{"rows":["ENSG00000186951"],"count":1},"linkedDiseases":{"rows":["EFO_0004319","EFO_0001645","EFO_0003768","EFO_0000319","EFO_0000311","EFO_0004211","HP_0002027","EFO_0003914","EFO_1001375","EFO_0000764","MONDO_0004975","EFO_0004272","MONDO_0007079","MONDO_0005148"],"count":14},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1981 and has 3 approved and 10 investigational indications."}
{"id":"CHEMBL4594614","drugType":"Unknown","blackBoxWarning":false,"name":"VIS-649","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Sibeprenlimab","VIS-649","VIS649","Vis-649","Vis649"],"description":"Unknown drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL460702","canonicalSmiles":"CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1","inchiKey":"VNBRGSXVFBYQNN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BMS-777607","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ASLAN-002","ASLAN002","BMS-777607","Bms-777607"],"crossReferences":{"PubChem":["137276001"],"drugbank":["DB12064"]},"linkedTargets":{"rows":["ENSG00000105976"],"count":1},"linkedDiseases":{"rows":["EFO_0000616"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4650381","drugType":"Unknown","blackBoxWarning":false,"name":"BMS-986120","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BMS-986120","Bms-986120"],"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4650405","drugType":"Protein","blackBoxWarning":false,"name":"LERODALCIBEP","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Lerodalcibep"],"description":"Protein drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4650407","drugType":"Unknown","blackBoxWarning":false,"name":"MATRIX-M1 ADJUVANT","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Matrix-m","Matrix-m1 adjuvant"],"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4650412","drugType":"Unknown","blackBoxWarning":false,"name":"OLESTRA","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Olean","Olestra"],"description":"Unknown drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4650477","drugType":"Oligonucleotide","blackBoxWarning":false,"name":"FRENLOSIRSEN SODIUM","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Frenlosirsen sodium","ION-251","ION-935918 SODIUM","ION251","Ion251"],"description":"Oligonucleotide drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL46740","canonicalSmiles":"Cc1c(-c2ccc(O)cc2)n(Cc2ccc(OCCN3CCCCCC3)cc2)c2ccc(O)cc12","inchiKey":"UCJGJABZCDBEDK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BAZEDOXIFENE","yearOfFirstApproval":2009,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Bazedoxifene"],"crossReferences":{"DailyMed":["bazedoxifene%20acetate"],"PubChem":["124893775"],"Wikipedia":["Bazedoxifene"],"drugbank":["DB06401"]},"childChemblIds":["CHEMBL2106615"],"linkedTargets":{"rows":["ENSG00000091831","ENSG00000140009"],"count":2},"linkedDiseases":{"rows":["EFO_0000685","MONDO_0041161","MONDO_0005301","EFO_0003854","EFO_0001065","MONDO_0007254","EFO_0000432","EFO_0003929","EFO_0003882","EFO_0001073","EFO_0003922"],"count":11},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2009 and is indicated for postmenopausal osteoporosis and has 8 investigational indications."}
{"id":"CHEMBL467754","canonicalSmiles":"CC(=O)N[C@H]1[C@H](O[C@@H]2[C@@H](CO)O[C@@H](O)[C@H](NC(C)=O)[C@H]2O)O[C@H](CO)[C@@H](O)[C@@H]1O","inchiKey":"CDOJPCSDOXYJJF-KSKNGZLJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHITODEXTRIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Chitodextrin"],"crossReferences":{"drugbank":["DB03013"],"chEBI":["50670"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL467888","canonicalSmiles":"C[C@@H]1CC[C@H]([C@@H](O)C(F)(F)F)N1c1ccc2[nH]c(=O)cc(C(F)(F)F)c2c1","inchiKey":"HWLLYFXDDGGHOE-BCSUUIJWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LGD-2941","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Lgd-2941"],"crossReferences":{"drugbank":["DB05234"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL488937","canonicalSmiles":"Cc1c(N)cccc1Cn1ccc(OCCc2cccs2)cc1=O","inchiKey":"YCLREGRRHGLOAK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CG-400549","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CG-400459","CG-400549","CG400549","Cg-400549","Cg400549","Nilofabicin"],"crossReferences":{"drugbank":["DB12347"]},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL494360","canonicalSmiles":"FC(F)(F)c1cccc(-c2nnc3ccc(NC4CCCCC4)nn23)c1","inchiKey":"XYYDXQCAYXOGQT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL494360","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08708"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL566752","canonicalSmiles":"CNc1ccc(/C=C/c2ccc(OCCOCCOCC[18F])cc2)cc1","inchiKey":"NCWZOASIUQVOFA-FWZJPQCDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FLORBETABEN F18","yearOfFirstApproval":2014,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1908906","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Neuraceq"],"synonyms":["BAY-949172","Florbetaben (18f)","Florbetaben f-18","Florbetaben f18","UNII-TLA7312TOI"],"crossReferences":{"DailyMed":["florbetaben%20f-18"],"drugbank":["DB09148"],"chEBI":["79033"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2014 and is indicated for cognitive impairment and alzheimer disease."}
{"id":"CHEMBL61301","canonicalSmiles":"Fc1ccc(Cn2c(NC3CCNCC3)nc3ccccc32)cc1","inchiKey":"SFOVDSLXFUGAIV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TECASTEMIZOLE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Norastemizole","Norastemizole (trivial name)","R-43512","Tecastemizole"],"crossReferences":{"drugbank":["DB06457"]},"childChemblIds":["CHEMBL1788380"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL62492","canonicalSmiles":"CC(C)COc1cccc(-c2nc3cc(C(=N)N)c(Cl)cc3[nH]2)c1O","inchiKey":"RTSLVPMQUZXPBZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL62492","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02989"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL63323","canonicalSmiles":"O=C(O)c1cccnc1Nc1cccc(C(F)(F)F)c1","inchiKey":"JZFPYUNJRRFVQU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NIFLUMIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NSC-758196","Niflugel","Niflumic acid","UP 83","UP-83"],"crossReferences":{"PubChem":["104171198","11111518","11111519","124880841","124880844","124880846","144203757","170466463","26747041","26751559","50104166","56423150","85231149","855922","90341015"],"drugbank":["DB04552"],"chEBI":["34888"]},"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL6594","canonicalSmiles":"Cc1cc(CCCCCOc2c(Cl)cc(C3=NCCO3)cc2Cl)on1","inchiKey":"JJDHAOLOHQTGMG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"WIN-54954","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["WIN-54954"],"crossReferences":{"drugbank":["DB08723"],"chEBI":["10029"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL70418","canonicalSmiles":"CN1C(=O)CC(=O)N(c2ccccc2)c2cc(Cl)ccc21","inchiKey":"CXOXHMZGEKVPMT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"CLOBAZAM","yearOfFirstApproval":2005,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Frisium","Onfi","Perizam","Sympazan","Tapclob","Urbanyl"],"synonyms":["Clobazam","Colbazam","H 4723","H-4723","HR 376","HR-376","LM 2717","LM-2717","Mystan","NSC-336279","Urbadan"],"crossReferences":{"DailyMed":["clobazam"],"PubChem":["144206161"],"Wikipedia":["Clobazam"],"drugbank":["DB00349"],"chEBI":["31413"]},"linkedTargets":{"rows":["ENSG00000022355","ENSG00000182256","ENSG00000011677","ENSG00000163285","ENSG00000151834","ENSG00000113327","ENSG00000186297"],"count":7},"linkedDiseases":{"rows":["EFO_0005762","MONDO_0005090","EFO_0000474","Orphanet_33069","MONDO_0002050","EFO_1000924","HP_0000726","HP_0003419","HP_0001250","Orphanet_2382","EFO_0005230","EFO_0003843"],"count":12},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2005 and has 3 approved and 9 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL75013","canonicalSmiles":"O=C(CCC1CCN(Cc2ccccc2)CC1)c1ccc2c(c1)NCCCC2","inchiKey":"PMBLXLOXUGVTGB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ZANAPEZIL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["TAK-147","Zanapezil"],"crossReferences":{"drugbank":["DB04859"]},"childChemblIds":["CHEMBL2358658"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL802","canonicalSmiles":"Nc1cc(N2CCCCC2)nc(N)[n+]1[O-]","inchiKey":"ZFMITUMMTDLWHR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"MINOXIDIL","yearOfFirstApproval":1979,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Loniten","Lonolox","Men's rogaine","Minodyl","Minoxidil","Minoxidil (for men)","Minoxidil (for women)","Minoxidil extra strength (for men)","Regaine for men","Regaine for women","Rogaine","Rogaine (for men)","Rogaine (for women)","Rogaine extra strength (for men)","Theroxidil","Women's rogaine"],"synonyms":["Alopexil","Alostil","Minoxidil","Minoximen","Mintop","NSC-757106","Normoxidil","Pierminox","Prexidil","Tricoxidil","U-10,858","U-10858"],"crossReferences":{"DailyMed":["minoxidil"],"PubChem":["104171187","11111457","11111458","11113580","144203744","170464704","26751784","26751785","46500395","50104471","85231134","90340717"],"Wikipedia":["Minoxidil"],"drugbank":["DB00350"],"chEBI":["6942"]},"linkedTargets":{"rows":["ENSG00000069431"],"count":1},"linkedDiseases":{"rows":["EFO_0005400","EFO_0004192","Orphanet_79364","MONDO_0022113","MONDO_0008170","EFO_0004191","MONDO_0003037","EFO_0000537"],"count":8},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1979 and has 4 approved indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL830","canonicalSmiles":"NCCCC(N)(C(=O)O)C(F)F","inchiKey":"VLCYCQAOQCDTCN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EFLORNITHINE","yearOfFirstApproval":1990,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Eflornithine","Ornidyl","Vaniqa"],"crossReferences":{"DailyMed":["eflornithine%20hydrochloride"],"PubChem":["174006789","575150","90341137"],"Wikipedia":["Eflornithine"],"drugbank":["DB06243"],"chEBI":["41948"]},"childChemblIds":["CHEMBL536971","CHEMBL1201037"],"linkedTargets":{"rows":["ENSG00000115758"],"count":1},"linkedDiseases":{"rows":["MONDO_0021440","DOID_10113","EFO_0005044","MONDO_0007576","EFO_0000313","EFO_0000621","MONDO_0008315","MONDO_0001187","EFO_1001951","EFO_0005225","MONDO_0001056","EFO_0009260","MONDO_0002974","Orphanet_733","MONDO_0021074","EFO_0004142","EFO_0002499"],"count":17},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1990 and is indicated for leishmaniasis and trypanosomiasis and has 14 investigational indications."}
{"id":"CHEMBL857","canonicalSmiles":"O=C(O)CCCC[C@@H]1SC[C@@H]2NC(=O)N[C@H]12","inchiKey":"YBJHBAHKTGYVGT-ZKWXMUAHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BIOTIN","yearOfFirstApproval":1985,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Bioepiderm","Biotin 100","Vitamin H"],"synonyms":["Biotin","D-biotin","MD-1003","NSC-63865","Ritatin"],"crossReferences":{"PubChem":["144206601","144212478","170464763","47193878","49674668"],"Wikipedia":["Biotin"],"drugbank":["DB00121"],"chEBI":["15956"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1985 and has 4 approved and 6 investigational indications."}
{"id":"CHEMBL862","canonicalSmiles":"N=C(N)NC(=O)Cc1c(Cl)cccc1Cl","inchiKey":"INJOMKTZOLKMBF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GUANFACINE","yearOfFirstApproval":1986,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Intuniv"],"synonyms":["Guanfacine","NSC-759121","Tenex"],"crossReferences":{"DailyMed":["guanfacine%20hydrochloride"],"PubChem":["104171166","11111221","11111222","11113866","124880211","26752038","90341397"],"Wikipedia":["Guanfacine"],"drugbank":["DB01018"],"chEBI":["5558"]},"childChemblIds":["CHEMBL1200494"],"linkedTargets":{"rows":["ENSG00000274286","ENSG00000184160","ENSG00000150594"],"count":3},"linkedDiseases":{"rows":["EFO_0003888","EFO_0004319","MONDO_0005090","EFO_0003756","EFO_0002610","EFO_1001219","HP_0012532","MONDO_0002009","EFO_0004329","MONDO_0001087","EFO_0003768","EFO_0001358","EFO_0009267","EFO_0000537","EFO_0007191","HP_0100543","EFO_0003890","HP_0012075","EFO_0004895","EFO_0000712","MONDO_0004975","MONDO_0007079","EFO_0003918","EFO_0005411"],"count":24},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1986 and is indicated for hypertension and attention deficit hyperactivity disorder and has 15 investigational indications."}
{"id":"CHEMBL96","canonicalSmiles":"NCCCC(=O)O","inchiKey":"BTCSSZJGUNDROE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GAMMA-AMINOBUTYRIC ACID","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[".gamma.-amino-n-butyric acid",".gamma.-aminobutyric acid","4-aminobutyric acid","Aminobutyric acid","Aminobutyric acid, gamma-","Butyric acid, 4-amino-","Factor i","Gamma-aminobutyrate","Gamma-aminobutyric acid","NSC-27418","Vigabatrin impurity, .gamma.-aminobutyric acid-"],"crossReferences":{"PubChem":["104171103","11110722","11113457","144203622","26751685","50104376","8139983","85230901","90341695"],"Wikipedia":["Gamma-Aminobutyric_acid"],"drugbank":["DB02530"],"chEBI":["16865"]},"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL985","canonicalSmiles":"NC(N)=O","inchiKey":"XSQUKJJJFZCRTK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"UREA","yearOfFirstApproval":1996,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Aquadrate","Balneum plus","Calmurid","Eucerin","Flexifoot","Flexitol","Hydromol intensive","Nutraplus","Sential e","St.james balm","Sterile urea","Ureaphil"],"synonyms":["Azodicarboxylic acid-diamide","Carbamide","E-927A","E927b","INS NO.927A","INS-927A","NSC-34375","Urea"],"crossReferences":{"DailyMed":["urea,%20c-14"],"PubChem":["144204587","144209356","144210355","17389689","49640652"],"Wikipedia":["Urea"],"drugbank":["DB03904"],"chEBI":["16199"]},"childChemblIds":["CHEMBL3184026","CHEMBL2096648","CHEMBL2096635"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1996 and is indicated for infection and has 11 investigational indications."}
